桂枝茯苓胶囊辅助西药治疗慢性盆腔炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R711.33

基金项目:


Clinical Study on Guizhi Fuling Capsules Assisting Western Medicine for Chronic Pelvic Inflammatory Disease
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察桂枝茯苓胶囊辅助西药治疗慢性盆腔炎(CPID) 的临床疗效。方法:将90 例CPID 患 者以随机数字表法分为研究组和对照组各45 例。对照组给予西药替硝唑片加盐酸左氧氟沙星胶囊治疗,研究 组在对照组基础上给予桂枝茯苓胶囊辅助治疗。比较2 组临床疗效,比较2 组治疗前后中医证候积分、盆腔血 流动力学[搏动指数(PI)、阻力指数(RI)、收缩期峰值血流速度(PSV)、最大血流速度(Vmax)] 及炎症 因子[白细胞介素-10(IL-10)、降钙素原(PCT)、超敏C-蛋白反应(hs-CRP)] 水平。结果:研究组总有 效率91.11%,高于对照组75.56%(P<0.05)。治疗后,2 组各项中医证候积分均降低(P<0.05),且研究组 低于对照组(P<0.05)。治疗后,2 组盆腔PI、RI 水平均降低(P<0.05),且研究组低于对照组(P<0.05), 2 组盆腔PSV、Vmax 水平均升高(P<0.05),且研究组高于对照组(P<0.05)。治疗后,2 组血清IL-10 水 平均升高(P<0.05),且研究组高于对照组(P<0.05),2 组血清PCT、hs-CRP 水平均降低(P<0.05),且研 究组低于对照组(P<0.05)。结论:针对CPID 患者临床给予桂枝茯苓胶囊辅助西药治疗,可进一步提升疗 效,缓解患者临床症状,改善盆腔血流动力学,减轻炎症反应。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Guizhi Fuling Capsules assisting western medicine on chronic pelvic inflammatory disease (CPID). Methods: A total of 90 cases of CPID patients were divided into the study group and the control group according to the random number table method, with 45 cases in each group. The control group was treated with Tinidazole Tablets and Levofloxacin Hydrochloride Capsules,and the study group was additionally treated with Guizhi Fuling Capsules based on the treatment of the control group. Clinical effects were compared between the two groups. Traditional Chinese medicine (TCM) syndrome scores, pelvic hemodynamics [pulsatile index (PI), resistance index (RI), peak systolic blood flow velocity (PSV), and maximum blood flow velocity (Vmax)], and levels of inflammatory factors [interleukin- 10 (IL-10),procalcitonin (PCT),and hypersensitive C-protein response (hs-CRP)] were compared between the two groups before and after treatment. Results:The total effective rate was 91.11% in the study group, higher than that of 75.56% in the control group (P<0.05). After treatment,each TCM syndrome score in the two groups was decreased when compared with that before treatment (P<0.05), and the scores in the study group were lower than those in the control group (P< 0.05). After treatment, the levels of pelvic PI and RI in the two groups were decreased when compared with those before treatment (P<0.05), and the levels in the study group were lower than those in the control group (P<0.05); the levels of pelvic PSV and Vmax in the two groups were increased when compared with those before treatment (P<0.05),and the levels in the study group were higher than those in the control group (P<0.05). After treatment,serum IL-10 levels in the two groups were increased when compared with those before treatment (P<0.05),and the level in the study group was higher than that in the control group (P<0.05); the levels of PCT and hs- CRP in serum in the two groups were decreased when compared with those before treatment (P<0.05),and the levels in the study group were lower than those in the control group (P<0.05). Conclusion: Guizhi Fuling Capsules assisting western medicine for patients with CPID can further enhance curative effects, relieve clinical symptoms, improve pelvic hemodynamics,and reduce inflammatory reactions.

    参考文献
    相似文献
    引证文献
引用本文

赵可,刘莉,任杰.桂枝茯苓胶囊辅助西药治疗慢性盆腔炎临床研究[J].新中医,2024,56(3):78-82

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-02-23
  • 出版日期:
文章二维码